skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > pyrimidodiazepine > ochrazepine d
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyrimidodiazepine > ochrazepine d
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyrimidodiazepine > ochrazepine d
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyrimidodiazepine > ochrazepine d
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > pyrimidodiazepine > ochrazepine d
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > pyrimidodiazepine > ochrazepine d
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > pyrimidodiazepine > ochrazepine d

Preferred term

ochrazepine d  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C26H25N3O8

inchi

  • InChI=1S/C26H25N3O8/c1-11-23-28-17-7-5-4-6-14(17)25(34)29(23)18-10-21(20(32)8-15(18)24(33)27-11)37-22(12(2)30)16-9-19(31)13(3)36-26(16)35/h4-13,19,22,30-32H,1-3H3,(H,27,33)/t11-,12-,13+,19-,22-/m0/s1

inchikey

  • RVTRFHDPNFYUPY-FEGBBNGISA-N

mass

  • 507.499

monoisotopicmass

  • 507.16416

smiles

  • O=C1N[C@H](C2=NC=3C=CC=CC3C(N2C4=C1C=C(O)C(=C4)O[C@H](C=5C(=O)O[C@H](C)[C@H](C5)O)[C@@H](O)C)=O)C

subset

  • 2_STAR

synonym EXACT

  • (7S)-3-hydroxy-2-[(1R,2S)-2-hydroxy-1-[(2R,3S)-3-hydroxy-2-methyl-6-oxo-2,3-dihydropyran-5-yl]propoxy]-7-methyl-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:208432

Download this concept:

RDF/XML TURTLE JSON-LD